BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lenihan D, Carver J, Porter C, Liu JE, Dent S, Thavendiranathan P, Mitchell JD, Nohria A, Fradley MG, Pusic I, Stockerl-Goldstein K, Blaes A, Lyon AR, Ganatra S, López-Fernández T, O'Quinn R, Minotti G, Szmit S, Cardinale D, Alvarez-Cardona J, Curigliano G, Neilan TG, Herrmann J. Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statement. CA Cancer J Clin 2020;70:480-504. [PMID: 32910493 DOI: 10.3322/caac.21635] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Abraham S, Manohar SA, Patel R, Saji AM, Dani SS, Ganatra S. Strategies for Cardio-Oncology Care During the COVID-19 Pandemic. Curr Treat Options Cardio Med. [DOI: 10.1007/s11936-022-00965-2] [Reference Citation Analysis]
2 Kondapalli L, Arora G, Hawi R, Andrikopoulou E, Estes C, Patel N, Lenneman CG. Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic. Curr Treat Options Oncol 2022. [PMID: 35969312 DOI: 10.1007/s11864-022-00997-7] [Reference Citation Analysis]
3 Ahmad J, Muthyala A, Kumar A, Dani SS, Ganatra S. Disparities in Cardio-oncology: Effects On Outcomes and Opportunities for Improvement. Curr Cardiol Rep 2022. [PMID: 35759170 DOI: 10.1007/s11886-022-01732-2] [Reference Citation Analysis]
4 Yu HX, Feng Z, Lin W, Yang K, Liu RQ, Li JQ, Liu XY, Pei M, Yang HT. Ongoing Clinical Trials in Aging-Related Tissue Fibrosis and New Findings Related to AhR Pathways. Aging Dis 2022;13:732-52. [PMID: 35656117 DOI: 10.14336/AD.2021.1105] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Gościniak P, Baumert B, Milczarek S, Jędrzychowska-baraniak J, Sobuś A, Machaliński B. The Impact of the COVID-19 Pandemic on the Organization of Cardio-Hematology Care—A Polish Single Center Experience. Medicina 2022;58:337. [DOI: 10.3390/medicina58030337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bisceglia I, Canale ML, Gallucci G, Turazza FM, Lestuzzi C, Parrini I, Russo G, Maurea N, Quagliariello V, Oliva S, Di Fusco SA, Lucà F, Tarantini L, Trambaiolo P, Moreo A, Geraci G, Gabrielli D, Gulizia MM, Oliva F, Colivicchi F. Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story. Front Cardiovasc Med 2022;9:821193. [DOI: 10.3389/fcvm.2022.821193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Herrmann J, López-Fernández T, Lyon AR. Year in cardiovascular medicine: cardio-oncology 2020-21. Eur Heart J 2022:ehab891. [PMID: 34974609 DOI: 10.1093/eurheartj/ehab891] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Xu Y, Peng W, Han D, Wang Z, Feng F, Zhou X, Wu Q. Material Basis and Mechanism of Chansu Injection for COVID-19 Treatment Based on Network Pharmacology and Molecular Docking Technology. Evid Based Complement Alternat Med 2021;2021:7697785. [PMID: 34671410 DOI: 10.1155/2021/7697785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bisceglia I, Gabrielli D, Canale ML, Gallucci G, Parrini I, Turazza FM, Russo G, Maurea N, Quagliariello V, Lestuzzi C, Oliva S, Di Fusco SA, Lucà F, Tarantini L, Trambaiolo P, Gulizia MM, Colivicchi F. ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO). Eur Heart J Suppl 2021;23:C128-53. [PMID: 34456641 DOI: 10.1093/eurheartj/suab067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Tehrani DM, Wang X, Rafique AM, Hayek SS, Herrmann J, Neilan TG, Desai P, Morgans A, Lopez-Mattei J, Parikh RV, Yang EH. Impact of cancer and cardiovascular disease on in-hospital outcomes of COVID-19 patients: results from the american heart association COVID-19 cardiovascular disease registry. Cardiooncology 2021;7:28. [PMID: 34372948 DOI: 10.1186/s40959-021-00113-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
11 Fonseka LN, Woo BK. Consumer Wearables and the Integration of New Objective Measures in Oncology: Patient and Provider Perspectives. JMIR Mhealth Uhealth 2021;9:e28664. [PMID: 34264191 DOI: 10.2196/28664] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Huang Y, Hu Z, Hu D, Quan Z, Zhou X, Fan G, Chen X, Liu X, Zhang Z, Chen G, Wu Y, Zhang F, Mao C, Xia H, Liang J, Yang B, Jiang H, Huang C, Barajas-Martínez H, Hu D. Clinical characteristics, risk factors, and cardiac manifestations of cancer patients with COVID-19. J Appl Physiol (1985) 2021;131:966-76. [PMID: 34236244 DOI: 10.1152/japplphysiol.00325.2021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Feldman S, Liu J, Steingart R, Gupta D. Cardio-oncology Training in the COVID-19 Era. Curr Treat Options Oncol 2021;22:58. [PMID: 34097148 DOI: 10.1007/s11864-021-00855-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Patel RP, Parikh R, Gunturu KS, Tariq RZ, Dani SS, Ganatra S, Nohria A. Cardiotoxicity of Immune Checkpoint Inhibitors. Curr Oncol Rep 2021;23:79. [PMID: 33937956 DOI: 10.1007/s11912-021-01070-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 13.0] [Reference Citation Analysis]
15 Sadler D, Arnold A, Herrmann J, Daniele A, Silva CMPDC, Ghosh AK, Szmit S, Khan RI, Raez L, Blaes A, Brown SA. Reaching Across the Aisle: Cardio-Oncology Advocacy and Program Building. Curr Oncol Rep 2021;23:64. [PMID: 33855620 DOI: 10.1007/s11912-021-01059-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Xiong W. Current status of treatment of cancer-associated venous thromboembolism. Thromb J 2021;19:21. [PMID: 33789658 DOI: 10.1186/s12959-021-00274-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
17 Fonseka LN, Woo BK. Consumer Wearables and the Integration of New Objective Measures in Oncology: Patient and Provider Perspectives (Preprint).. [DOI: 10.2196/preprints.28664] [Reference Citation Analysis]
18 Martínez-monzonís A, Barreiro-pérez M, Li C, Jiménez-borreguero J, Guzmán G, Fernández-golfín C, Aguadé Bruix S, López-fernandez T. Selección de lo mejor del año 2020 en imagen cardiovascular. REC: CardioClinics 2021;56:59-65. [DOI: 10.1016/j.rccl.2020.10.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Dani SS, Bagga S, Ganatra S. Editorial commentary: Cardiovascular imaging in COVID-19: Focus on safety, value, and clinical relevance. Trends Cardiovasc Med 2021;31:17-9. [PMID: 33161098 DOI: 10.1016/j.tcm.2020.10.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Dal'bo N, Patel R, Parikh R, Shah SP, Guha A, Dani SS, Ganatra S. Cardiotoxicity of Contemporary Anticancer Immunotherapy. Curr Treat Options Cardiovasc Med 2020;22:62. [PMID: 33162729 DOI: 10.1007/s11936-020-00867-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]